A team of clinician-scientists and scientists, led by the National Cancer Centre Singapore (NCCS) and A*STAR's Genome Institute of Singapore (GIS) together with collaborators in Europe and South Korea, used single cell techniques ...
Jul 1, 2022
0
65
An oral antiviral drug that targets a key part of the respiratory syncytial virus (RSV) polymerase and inhibits the synthesis of viral genetic material has been identified, a finding that could provide an effective treatment ...
Jun 24, 2022
0
112
A novel staging framework that assesses the progression of Huntington's disease (HD), similar to the way cancer is staged 0 to 4, has been developed by UCL scientists as part of an international consortium; this 'significant' ...
Jun 16, 2022
0
11
A new study presents a novel approach to drug repurposing that incorporates two-stage prediction and machine learning. The study is published in the peer-reviewed OMICS: A Journal of Integrative Biology.
Jun 7, 2022
0
5
New insights into how genetic factors affect the body's immune response in type 1 diabetes have been published in eLife.
Jun 7, 2022
0
18
A newly discovered inhibitor of a common cancer-causing protein operates selectively, reducing expression of genes that fuel rampant cell proliferation and alter the epigenome, according to a Northwestern Medicine study published ...
Jun 6, 2022
0
52
Research scientists and statisticians from UC San Francisco have developed improved biomarker classifications as part of their research results in the I-SPY 2 trial for high-risk breast cancer patients. The new cancer response ...
Jun 4, 2022
0
3
Biomedical researchers develop and use organoids as a tool for studying human development and disease. These little lab-grown cultures mimic human organs and provide a sharp view of tissue development, drug interaction, and ...
May 26, 2022
0
8
An interactive web portal developed by scientists at KAUST offers a platform for cancer researchers to interrogate how RNA splicing in noncoding parts of genes fuels the growth of different types of tumors.
May 26, 2022
0
54
Populations underrepresented in clinical trials face worse health outcomes that will cost the U.S. trillions of dollars over the next three decades, according to a new report from the National Academies of Science, Engineering ...
May 19, 2022
0
2
